[go: up one dir, main page]

AU1459792A - Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods - Google Patents

Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods

Info

Publication number
AU1459792A
AU1459792A AU14597/92A AU1459792A AU1459792A AU 1459792 A AU1459792 A AU 1459792A AU 14597/92 A AU14597/92 A AU 14597/92A AU 1459792 A AU1459792 A AU 1459792A AU 1459792 A AU1459792 A AU 1459792A
Authority
AU
Australia
Prior art keywords
hcv
epitopes
vaccines
antibodies
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14597/92A
Inventor
Bahige M Baroudy
Girish J. Kotwal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gamble James N Institute of Medical Research
Original Assignee
Gamble James N Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gamble James N Institute of Medical Research filed Critical Gamble James N Institute of Medical Research
Publication of AU1459792A publication Critical patent/AU1459792A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K16/118—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
AU14597/92A 1991-01-14 1992-01-14 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods Abandoned AU1459792A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63980991A 1991-01-14 1991-01-14
US639809 1991-01-14
USNOTGIVEN 1998-02-02

Publications (1)

Publication Number Publication Date
AU1459792A true AU1459792A (en) 1992-08-27

Family

ID=24565635

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14597/92A Abandoned AU1459792A (en) 1991-01-14 1992-01-14 Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods

Country Status (3)

Country Link
EP (1) EP0571554A1 (en)
AU (1) AU1459792A (en)
WO (1) WO1992012992A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105871D0 (en) * 1991-03-20 1991-05-08 Inst Cientifico Tecnol Navarra Synthetic peptides
DE4209215A1 (en) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh HCV PEPTIDE ANTIGEN AND METHOD FOR DETERMINING HCV
CA2120340A1 (en) * 1991-10-02 1994-04-15 Kaichiro Ishibashi Reagents for testing for hepatitis c and method of testing for the same
DE4240980A1 (en) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV peptide antigens and method for the determination of HCV
JPH06311885A (en) * 1992-08-25 1994-11-08 Mitsubishi Kasei Corp Anti-sense compound complementary with gene of hepatitis c virus
US6174868B1 (en) * 1992-09-10 2001-01-16 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
NZ286209A (en) * 1992-09-10 2000-09-29 Isis Pharmaceuticals Inc Use of HCV RNA anti-sense nucleotide sequences for treating Hepatitis C virus related disease
JPH10503364A (en) * 1994-05-10 1998-03-31 ザ ジェネラル ホスピタル コーポレーション Antisense inhibition of hepatitis C virus
AU707811B2 (en) * 1995-05-05 1999-07-22 Australian Water Technologies Pty Ltd Method for the detection of viable Cryptosporidium parvum oocysts
AUPN283195A0 (en) * 1995-05-05 1995-06-01 Australian Water Technologies Pty Ltd Method for the detection of viable cryptosporidium parvum cells
IT1285158B1 (en) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio SOLUBLE POLYPEPTIDES WITH THE SERINO-PROTEASIS ACTIVITY OF NS3 OF THE HEPATITIS C VIRUS, AND PROCEDURE FOR THEIR PREPARATION AND
DE19980730D2 (en) * 1998-04-28 2001-05-10 Wolfgang Bergter Radioimmunopharmaceuticals for the treatment of hepatitis C

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017157C (en) * 1989-05-18 2003-07-29 Michael Houghton Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
CA2032907C (en) * 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay
KR940000755B1 (en) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Synthetic peptides that are particularly suitable for detecting antibodies to HCV, diagnosing HCV infections and their prevention as vaccines
ZA912040B (en) * 1990-03-30 1991-12-24 Akzo Nv Peptides immunochemically reactive with antibodies directed against hepatitis non-a,non-b virus
HUT69140A (en) * 1990-08-10 1995-08-28 Chiron Corp Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
JP3114731B2 (en) * 1990-08-14 2000-12-04 国立感染症研究所長 Peptide antigen for detecting hepatitis C virus antibody and method of using the same
ES2070415T3 (en) * 1990-10-05 1995-06-01 Akzo Nobel Nv IMMUNOCHEMICALLY REACTIVE PEPTIDES WITH ANTIBODIES DIRECTED AGAINST HEPATITIS NO-A, NO-B VIRUSES.
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
ES2095852T3 (en) * 1990-12-14 1997-03-01 Innogenetics Nv SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES AGAINST THE HEPATITIS C VIRUS.

Also Published As

Publication number Publication date
EP0571554A1 (en) 1993-12-01
WO1992012992A2 (en) 1992-08-06
WO1992012992A3 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
WO1993000365A3 (en) Hepatitis c virus (hcv) polypeptides
AU9052091A (en) Vaccines based on hepatitis b surface antigen
AU2497292A (en) Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
NZ236491A (en) Post-transfusional non-a non-b hepatitis viral polypeptides, dna, antigenic polypeptides and antibodies to the polypeptides
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
IL122589A0 (en) Vaccines against hepatitis c
GB9324607D0 (en) Hepatitis c diagnostics and vaccines
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU2699192A (en) Enhanced immunogenicity using leukotoxin chimeras
AU1459792A (en) Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
GB8921470D0 (en) Vaccines
ZA885774B (en) Vaccines in which the characteristic epitope is incorporated in a protein of a picornavirus,in particular of poliovirus
HUT65448A (en) New immunogenic polypeptides, vaccines containing them and method for preparation and use of them
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
AU2549584A (en) Enhancing vaccines: antigenicity
IL90408A0 (en) Method for producing non-hyperglycosylated hepatitis b virus proteins
AU3772389A (en) Haemophilus influenzae pilus vaccines
AU7713387A (en) Hepatitis vaccine
EP0093438A3 (en) Non-a, non-b hepatitis antigen
NZ223624A (en) Peptide immunogen from streptococcus mutans, vaccines and antibodies
AU5873094A (en) Multivalent ab1 antibodies as vaccines
AU4863490A (en) Polypeptides, antigens or vaccines protective against babesiosis
AU3751093A (en) Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine